Skip to content

Clinical trials

Completed Alzheimer Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Belgium Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20082
20091
20102
20112
20121
20137
20148
20154
20164
20174
20181
20191
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC10
Pfizer4
Alnylam Pharmaceuticals2
Boehringer Ingelheim2
H. Lundbeck A/S2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
TauRx Therapeutics Ltd2
Universitaire Ziekenhuizen KU Leuven2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease45
Dementia6
Amyloid Neuropathies, Familial4
Cognitive Dysfunction4
Neurodegenerative Diseases4
Amyloidosis3
Cardiomyopathies3
Memory Disorders3
Heart Failure2
Lewy Body Disease2

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.